A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer Article

cited authors

  • Kim, Dae Won; Tan, Elaine; Zhou, Jun-Min; Schell, Michael J.; Martinez, Maria; Yu, James; Carballido, Estrella; Mehta, Rutika; Strosberg, Jonathan; Imanirad, Iman; Kim, Richard D.

Publication Date

  • April 7, 2021

webpage

published in

category

start page

  • 1803

end page

  • 1808

volume

  • 124

issue

  • 11